We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

131 hedge funds and large institutions have $391M invested in DIPLOMAT PHARMACY, INC. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 27 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 27

13% more capital invested

Capital invested by funds: $345M → $391M (+$45.5M)

13% less funds holding

Funds holding: 150131 (-19)

44% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 34

75% less call options, than puts

Call options by funds: $568K | Put options by funds: $2.24M

Holders
131
Holders Change
-19
Holders Change %
-12.67%
% of All Funds
2.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
57
Reduced
27
Closed
34
Calls
$568K
Puts
$2.24M
Net Calls
-$1.68M
Net Calls Change
-$2.64M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$55.7M +$3.27M +614,918 +7%
DM
2
Deerfield Management
New York
$42.9M -$67.1K -12,627 -0.2%
SI
3
Stephens Inc
Arkansas
$40.2M +$32.9M +6,182,889 +1,482%
Vanguard Group
4
Vanguard Group
Pennsylvania
$34.8M +$986K +185,431 +3%
Capital World Investors
5
Capital World Investors
California
$31.2M -$1.13M -211,717 -4%
Capital International Investors
6
Capital International Investors
California
$20.2M +$2M +375,900 +13%
AC
7
Armistice Capital
New York
$19.5M +$1.06M +200,000 +7%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$13.6M -$91.2K -17,167 -0.8%
State Street
9
State Street
Massachusetts
$11.5M -$1.03M -194,021 -9%
JP Morgan Chase
10
JP Morgan Chase
New York
$8.63M +$6.12M +1,150,740 +390%
Northern Trust
11
Northern Trust
Illinois
$7.84M +$62K +11,656 +0.9%
Invesco
12
Invesco
Georgia
$7.43M +$2.26M +424,647 +53%
RPAM
13
Rhenman & Partners Asset Management
Sweden
$7.33M
Deutsche Bank
14
Deutsche Bank
Germany
$6.12M +$1.87M +351,124 +54%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$6.03M +$1.19M +224,067 +29%
Charles Schwab
16
Charles Schwab
California
$5.21M +$1.05M +198,315 +30%
Cambridge Investment Research Advisors
17
Cambridge Investment Research Advisors
Iowa
$4.92M -$1.33K -250 -0%
FCM
18
Frontier Capital Management
Massachusetts
$4.7M -$1.7M -320,046 -29%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$4.28M +$257K +48,434 +7%
MCM
20
Matarin Capital Management
New York
$4.27M +$34.7K +6,537 +0.9%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$4.13M +$156K +29,327 +5%
UBS Group
22
UBS Group
Switzerland
$3.93M +$3.41M +641,118 +14,087%
STB
23
S&T Bank
Pennsylvania
$3.72M +$312K +58,747 +11%
ASN
24
Advisory Services Network
Georgia
$3.65M
Principal Financial Group
25
Principal Financial Group
Iowa
$2.77M +$3.02K +568 +0.1%

DPLO Hedge Fund Activity: Q2 2019 in Review

131 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q2 2019, worth a combined $391M — up 13% from $345M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of DPLO and 19 opened new positions — a net loss of 15 holders — while 27 trimmed existing stakes and 57 added.

The largest buyer was Stephens Inc, adding an estimated $32.9M. The largest seller was Millennium Management, exiting entirely with an estimated $9.31M sold.

  • 131 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q2 2019, down from 150 in Q1 2019.
  • Funds reported $391M of DIPLOMAT PHARMACY, INC. stock for Q2 2019, up 13% quarter-over-quarter.
  • 19 funds opened new DIPLOMAT PHARMACY, INC. positions in Q2 2019 and 34 closed out, a net change of -15 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q2 2019 was Stephens Inc, an estimated $32.9M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q2 2019 was Millennium Management, an estimated $9.31M sold.

Based on aggregated 13F filings for Q2 2019.